Yong-Mei Zhang Selected Research

1-ethyl-2-benzimidazolinone

1/2020	Predisposition of Neonatal Maternal Separation to Visceral Hypersensitivity via Downregulation of Small-Conductance Calcium-Activated Potassium Channel Subtype 2 (SK2) in Mice.
1/2020	Small-Conductance Ca2+-Activated K+ Channels 2 in the Hypothalamic Paraventricular Nucleus Precipitates Visceral Hypersensitivity Induced by Neonatal Colorectal Distension in Rats.
1/2018	Small-Conductance Ca2+-Activated K+ Channel 2 in the Dorsal Horn of Spinal Cord Participates in Visceral Hypersensitivity in Rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yong-Mei Zhang Research Topics

Disease

9	Hypersensitivity (Allergy) 01/2022 - 01/2016
8	Pain (Aches) 01/2022 - 08/2009
6	Ischemia 11/2010 - 10/2002
6	Reperfusion Injury 11/2010 - 04/2002
4	Traumatic Brain Injuries (Traumatic Brain Injury) 05/2021 - 01/2012
4	Hyperalgesia 05/2021 - 01/2020
4	Inflammation (Inflammations) 01/2020 - 01/2009
4	Brain Injuries (Brain Injury) 01/2019 - 04/2011
3	Visceral Pain 05/2022 - 08/2018
3	Neoplasms (Cancer) 01/2020 - 06/2006
3	Infections 01/2018 - 04/2014
3	Substance Withdrawal Syndrome (Withdrawal Symptoms) 02/2016 - 10/2015
2	Hepatitis B 02/2018 - 06/2015
2	Morphine Dependence 02/2016 - 01/2016
2	Opioid-Related Disorders (Opiate Addiction) 02/2016 - 01/2016
2	Hypoxia (Hypoxemia) 06/2013 - 10/2010
2	Hypoglycemia (Reactive Hypoglycemia) 01/2012 - 03/2007
2	Nephritis 04/2009 - 01/2009
2	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2007 - 03/2005
1	Irritable Bowel Syndrome (Syndrome, Irritable Bowel) 01/2022
1	Diabetes Mellitus 01/2020
1	Anaphylaxis (Anaphylactic Shock) 01/2020
1	Heart Arrest (Cardiac Arrest) 01/2019
1	Chronic Hepatitis B 02/2018
1	Leukemia 12/2017
1	B-Cell Lymphoma (Lymphoma, B Cell) 12/2017
1	Chronic Pain 01/2016
1	Acute Pain 01/2016
1	Osteosarcoma (Osteogenic Sarcoma) 01/2016
1	Hepatitis 06/2015

Drug/Important Bio-Agent (IBA)

12	Proteins (Proteins, Gene)FDA Link 01/2020 - 01/2006
5	Corticotropin-Releasing HormoneIBA 01/2022 - 01/2016
4	CytokinesIBA 05/2022 - 01/2016
3	Neutralizing AntibodiesIBA 05/2022 - 01/2020
3	Interleukin-6 (Interleukin 6)IBA 05/2022 - 01/2020
3	Lidocaine (Xylocaine)FDA LinkGeneric 05/2021 - 01/2016
3	Morphine (MS Contin)FDA LinkGeneric 05/2021 - 01/2016
3	1-ethyl-2-benzimidazolinoneIBA 01/2020 - 01/2018
3	Toll-Like Receptor 4IBA 01/2017 - 06/2013
3	Naloxone (Narcan)FDA LinkGeneric 02/2016 - 10/2015
3	Serotonin (5 Hydroxytryptamine)IBA 02/2016 - 10/2015
3	Pharmaceutical PreparationsIBA 01/2016 - 03/2005
3	Propofol (Diprivan)FDA LinkGeneric 12/2013 - 02/2013
3	Arachidonate 15-Lipoxygenase (Arachidonate 15 Lipoxygenase)IBA 04/2010 - 01/2009
3	lipoxin A4IBA 04/2010 - 01/2009
3	LeukotrienesIBA 04/2010 - 01/2009
3	pantothenate kinaseIBA 01/2007 - 03/2005
2	Minocycline (Cyclops)FDA LinkGeneric 05/2022 - 01/2016
2	Dopamine (Intropin)FDA LinkGeneric 05/2021 - 08/2018
2	gamma-Aminobutyric Acid (GABA)IBA 01/2021 - 01/2020
2	Caspase 3 (Caspase-3)IBA 01/2021 - 12/2017
2	Calcium-Activated Potassium Channels (Calcium-Activated Potassium Channel)IBA 01/2020 - 01/2020
2	ApaminIBA 01/2020 - 01/2020
2	Small Interfering RNA (siRNA)IBA 01/2020 - 01/2016
2	Transcription Factors (Transcription Factor)IBA 01/2020 - 01/2016
2	Messenger RNA (mRNA)IBA 01/2017 - 01/2016
2	lorcaserinIBA 02/2016 - 10/2015
2	Clonidine (ST 155)FDA LinkGeneric 02/2016 - 10/2015
2	Adrenergic Receptors (Adrenergic Receptor)IBA 02/2016 - 10/2015
2	5-HT2C Serotonin ReceptorIBA 02/2016 - 10/2015
2	Myeloid Differentiation Factor 88IBA 01/2016 - 02/2013
2	Neuroprotective AgentsIBA 12/2013 - 04/2011
2	NF-kappa B (NF-kB)IBA 02/2013 - 01/2008
2	Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP)IBA 07/2012 - 01/2012
2	Fatty Acids (Saturated Fatty Acids)IBA 01/2012 - 06/2006
2	LipoxinsIBA 04/2010 - 01/2009
2	Angiotensin IIIBA 05/2008 - 01/2008
2	Protein Isoforms (Isoforms)IBA 01/2007 - 01/2006
1	erythromycin propionate-N-acetylcysteinateIBA 01/2022
1	Interleukin-15 (Interleukin 15)IBA 05/2021
1	Analgesics (Analgesic Drugs)IBA 05/2021
1	Therapeutic UsesIBA 01/2020
1	Freund's AdjuvantIBA 01/2020
1	N'- (3,4- dihydroxybenzylidene)- 3- hydroxy- 2- naphthahydrazideIBA 01/2020
1	Membrane Proteins (Integral Membrane Proteins)IBA 01/2020
1	MuscimolIBA 01/2020
1	Granzymes (Granzyme)IBA 01/2019
1	Alanine Transaminase (SGPT)IBA 02/2018
1	Biomarkers (Surrogate Marker)IBA 02/2018
1	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 01/2018
1	Interleukin-23 (Interleukin 23)IBA 12/2017
1	Vorinostat FDA Link 12/2017
1	Interleukin-17 (Interleukin 17)IBA 12/2017
1	6- cyclopropylmethyl- 2- (2,4- dichlorophenyl)- 7- ethyl- 4- methyl- 7,8- dihydro- 6H- 1,3,6,8a- tetraazaacenaphthyleneIBA 01/2017
1	lipopolysaccharide AIBA 01/2017
1	Glucocorticoid Receptors (Glucocorticoid Receptor)IBA 03/2016
1	Nicotine FDA Link 02/2016
1	Cocaine (Cocaine HCl)IBA 02/2016
1	Acetic Acid (Vinegar)FDA LinkGeneric 01/2016
1	ZymosanIBA 01/2016
1	Heroin (Diamorphine)IBA 10/2015
1	Hepatitis B e AntigensIBA 06/2015
1	AntigensIBA 06/2015
1	CaveolinsIBA 01/2015

Therapy/Procedure

2	Therapeutics 01/2022 - 05/2021
1	Spinal Injections 01/2020
1	Subcutaneous Injections 01/2020
1	Resuscitation 01/2019
1	Cardiopulmonary Resuscitation (CPR) 01/2019
1	Analgesia 03/2016